mirtazapine

Conclusion Mirtazapine has diphasic action of anti-depression and-anxiety, its effect of anti-depression is equivalent to imipramine and that of anti-anxiety superior to imipramine, and has significant efficacy, higher safety and better compliance in depression associated with anxious symptoms.

结论米氮平具有抗抑郁抗焦虑双重作用，抗抑郁作用与丙米嗪相当，抗焦虑作用优于丙米嗪，治疗抑郁症伴焦虑症状疗效显著，安全性高、依从性好。

The structure-activity relationship, pharmacology , pharmacokinetics, clinical efficacy , ADRs, and drug interaction of mirtazapine antidepressant, are reviewed.

综述米氮平的化学构效关系, 药理 、 药动学 、 临床应用以及不良反应和药物相互作用.

Conclusion: mirtazapine had good effectiveness in the depressed patients with anxiety symptoms.

结论：米氮平对伴有焦虑症状的抑郁症有良好的疗效。

Comparative Study of Mirtazapine and Citalopram in Treatment of Somatoform Disorder

米氮平与西酞普兰治疗躯体形式障碍的对照研究

Clinical application of mirtazapine

米氮平的临床应用

Comparisons of clinical efficacy of mirtazapine in the treatment of depression and anxiety

米氮平治疗抑郁症及焦虑症的临床疗效比较

Effect of Mirtazapine on Irritable Bowel Syndrome and Changes of Neuropeptide-Y Level

米氮平联合匹维溴胺治疗肠易激综合征的效果及其对神经肽Y水平的影响

Mirtazapine responded more quickly and showed significant improvement of anxiety symptoms at the beginning of the treatment.

目的：比较米氮平与帕罗西汀治疗伴有焦虑症状抑郁症的疗效。

Comparative Study of Mirtazapine and Fluoxetine in the Treatment of Senile Depression

米氮平与氟西丁治疗老年抑郁症患者的对照研究

Mirtazapine in the Treatment of Depression Associated with Anxiety

米氮平治疗伴有焦虑的抑郁症

Conclusion Mirtazapine is a safe, effective antidepressant with rapid response.

结论米氮平是一种安全、有效的新型抗抑郁药物，起效较快。

Objective To explore the efficacy and side effects of mirtazapine in the treatment of depression in childhood.

目的探讨米氮平治疗儿童抑郁症患者的疗效及不良反应。

Objective To explore efficacy and side effects of mirtazapine.

目的探讨米氮平治疗抑郁症的疗效与安全性。

The observation on the effect of mirtazapine combined with cognitive therapy in the treatment of post-stroke depression

米氮平联合认知疗法治疗脑卒中后抑郁的疗效观察

Objective: To evaluate the efficacy and safety of mirtazapine in the treatment of cardiovascular neurosis with depression.

目的：评价米氮平治疗伴抑郁的心血管神经症的临床疗效和安全性。

Clinical comparative analysis of Venlafaxine versus Mirtazapine in the treatment of depression

文拉法辛与米氮平治疗抑郁症的临床比较分析

Research of metabolism of antidepressant mirtazapine on mice liver microsome in vitro

米氮平在鼠肝微粒体中的体外代谢研究

The Study of Mirtazapine in the Treatment of Patients with Post-schizophrenic Depression

米氮平治疗精神分裂症后抑郁的临床研究

Clinical Evaluation of Mirtazapine and Clomipramine for the Treatment of Depressive Disorder Associated with Anxiety

米氮平与氯丙米嗪治疗抑郁症伴有焦虑的临床评价

A Comparative Study of Mirtazapine and Fluoxetine in Treatment of Elderly Depressive Patients with Insomnia

米氮平与氟西汀治疗以失眠为主诉的老年抑郁症患者的对照研究

Objectives : To compare the efficacy of methadone with mirtazapine or benzodiazepines in heroin detoxification.

目的: 比较米氮平与苯二氮类药物合并美沙酮治疗对海洛因依赖者脱毒疗效.

Objective: To investigate the clinical efficacy and compliance with a new antidepressant mirtazapine to treat depressive patients.

目的：探讨新型抗抑郁药物米氮平的临床疗效及治疗依从性。

Comparison of Therapeutic Effects between Mirtazapine and Alprazolam on Chronic Insomnia

米氮平与阿普唑仑治疗慢性失眠症的临床疗效比较

Conclusion: Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression.

结论：抑郁症患者对米氮平依从性高主要是因疗效好，不良反应轻。

Mirtazapine and Fluoxetine in Treating Depression: Cost-minimization Analysis

米氮平与氟西汀治疗抑郁症的最小成本分析

Evaluation of cognitive function in post-stroke depressive patients treated with mirtazapine by using P300

应用P300评估脑卒中后抑郁患者米氮平治疗前后认知功能的变化

Results The efficacy rate of mirtazapine was 87.8% in which 61% were improved markedly.

结果米氮平治疗抑郁症有效率87.7%，显效率61%，未见严重不良反应。

The Phase IIb trials in the Japanese population demonstrated superior efficacy of mirtazapine oer placebo.

在日本病人体内进行的二期b阶段 的临床实验表明,米尔塔扎平的效力远远高于对照品.

Objective : To evaluate the efficacy and safety of mirtazapine combined with lithium carbonate on bipolar depression.

目的: 评价米氮平联用碳酸锂治疗双相抑郁的疗效及其安全性.

Conclusion Mirtazapine is of good efficacy, rapid action, and less side effects in treatment of depression.

结论米氮平治疗抑郁症疗效好、起效快、副反应较低。